{"id":155525,"date":"2021-05-26T01:51:24","date_gmt":"2021-05-26T05:51:24","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/vor-biopharma-to-present-at-jefferies-and-goldman-sachs-investor-conferences\/"},"modified":"2024-08-18T11:42:49","modified_gmt":"2024-08-18T15:42:49","slug":"vor-biopharma-to-present-at-jefferies-and-goldman-sachs-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/vor-biopharma-to-present-at-jefferies-and-goldman-sachs-investor-conferences.php","title":{"rendered":"Vor Biopharma to Present at Jefferies and Goldman Sachs Investor Conferences"},"content":{"rendered":"<p><![CDATA[CAMBRIDGE, Mass., May  25, 2021  (GLOBE NEWSWIRE) -- Vor Biopharma (Nasdaq: VOR or the Company), a cell therapy company pioneering engineered hematopoietic stem cell (eHSC) therapies combined with targeted therapies for the treatment of cancer, today announced that the Robert Ang, MBBS, MBA, Vor\u2019s President and Chief Executive Officer, and Nathan Jorgensen, Ph.D., Vor\u2019s Chief Financial Officer, are scheduled to present at the following conferences:]]><\/p>\n<p>Originally posted here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"https:\/\/www.globenewswire.com\/news-release\/2021\/05\/25\/2235928\/0\/en\/Vor-Biopharma-to-Present-at-Jefferies-and-Goldman-Sachs-Investor-Conferences.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Vor Biopharma to Present at Jefferies and Goldman Sachs Investor Conferences\">Vor Biopharma to Present at Jefferies and Goldman Sachs Investor Conferences<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Originally posted here: Vor Biopharma to Present at Jefferies and Goldman Sachs Investor Conferences <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/vor-biopharma-to-present-at-jefferies-and-goldman-sachs-investor-conferences.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-155525","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/155525"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=155525"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/155525\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=155525"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=155525"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=155525"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}